ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 89 filers reported holding ERASCA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,485 | +138.2% | 12,429 | +233.8% | 0.00% | – |
| Q2 2023 | $10,278 | +29265.7% | 3,724 | -67.7% | 0.00% | -100.0% |
| Q1 2023 | $35 | +775.0% | 11,526 | +1180.7% | 0.00% | – |
| Q4 2022 | $4 | -100.0% | 900 | -81.7% | 0.00% | -100.0% |
| Q3 2022 | $38,000 | +15.2% | 4,910 | -17.5% | 0.00% | 0.0% |
| Q2 2022 | $33,000 | -50.7% | 5,949 | -23.5% | 0.00% | 0.0% |
| Q1 2022 | $67,000 | +148.1% | 7,775 | +348.1% | 0.00% | – |
| Q4 2021 | $27,000 | +28.6% | 1,735 | +76.9% | 0.00% | -100.0% |
| Q3 2021 | $21,000 | – | 981 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 11,055,554 | $21,779,441 | 14.15% |
| EDBI Pte Ltd | 888,888 | $1,751,109 | 1.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,926,000 | $3,794,220 | 1.28% |
| Cormorant Asset Management, LP | 10,813,246 | $21,302,095 | 1.24% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $615,625 | 0.64% |
| Artal Group S.A. | 4,721,194 | $9,301 | 0.40% |
| PFM Health Sciences, LP | 3,930,633 | $7,743,347 | 0.36% |
| ARMISTICE CAPITAL, LLC | 8,356,000 | $16,461,320 | 0.25% |
| SANDERS MORRIS HARRIS LLC | 425,297 | $816,569 | 0.17% |
| Prosight Management, LP | 264,710 | $521,479 | 0.16% |